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Abstract  47 
Introduction 48 
Urogenital symptoms are prevalent in older women but there is little data available on the 49 
prevalence, bother, impact and associations with low back pain (LBP), obesity, parity, mental 50 
health (MH), and quality of life (QOL) in young women. 51 
Objectives 52 
To determine the prevalence, bother and impact of urogenital symptoms, and to explore 53 
associations with LBP, obesity, parity, MH and QOL in 22 year-old women. 54 
Methods 55 
A cross sectional evaluation using data collected from 588 women in the Raine Study, a 56 
pregnancy cohort in which participants have been regularly followed up from birth until 22 57 
years. Data was analysed using descriptive statistics, univariate comparisons and linear 58 
regression models.  59 
Results 60 
Prevalence of urogenital symptoms were: stress urinary incontinence (SUI) 6.3%; mixed 61 
urinary incontinence (MUI) 11.5%; leakage of drops 5.8%; urge urinary incontinence (UUI) 62 
5.3%; bothersome urinary frequency 41.5%; difficulty emptying 11.8% and urogenital pain 63 
22.9%. Urinary frequency, MUI, difficulty emptying and urogenital pain were most 64 
bothersome, whilst difficulty emptying and urogenital pain were associated with greatest 65 
impact. Urinary frequency, SUI, leakage of drops, difficulty emptying and urogenital pain 66 
were associated with current LBP and LBP ever. Difficulty emptying and urogenital pain 67 
were associated with chronic LBP. Urogenital symptoms were not associated with obesity or 68 
parity. Women with urogenital symptoms had significantly poorer scores on Mental 69 
Component Score of the SF-12 and all aspects of the Depression Anxiety Stress Score. 70 
Conclusions  71 
Urogenital symptoms are prevalent in young women, and bothersome for some. They are 72 
associated with LBP, poorer MH and QOL. 73 
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Keywords  75 
lower urinary tract symptoms; mental health; prevalence; quality of life; urinary incontinence; 76 
urogenital pain. 77 
Brief Summary  78 
Urogenital symptoms are prevalent in young women. They are associated with low back 79 
pain, poorer mental health and quality of life, and negative functional impact.  80 
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Introduction 81 
 82 
Urogenital symptoms such as urinary incontinence (UI), lower urinary tract symptoms 83 
(LUTS) and urogenital pain have been associated with significant bother and impact, 84 
obesity, parity, low back pain (LBP), poorer mental wellbeing and poorer quality of life (QOL) 85 
in middle aged and older women, however there is less data available pertaining specifically 86 
to young women [1, 2, 4-6]. In addition, prevalence studies tend to cluster women from age 87 
18 to the 30’s, and suggest that at some point between late adolescence and early 88 
adulthood, the prevalence of UI and LUTS begins to increase, but little data is available on 89 
the age at which this occurs, or on the factors associated with these changes, therefore 90 
more specific estimates during early adulthood may be beneficial [3, 8, 9]. Practically, 91 
understanding this transition period may allow for improved prevention and management 92 
strategies and inform when to target such measures. 93 
Recent research suggests that urogenital symptoms do not occur in isolation but are 94 
associated with other pain problems and mental health related factors [2]. However there is 95 
little data available for young women, and therefore detailed comorbidity patterns are not 96 
established for younger women. Understanding comorbidities could assist in the design of 97 
holistic management programs.  98 
Aims 99 
The first aim was to estimate the prevalence, bother and impact of urogenital symptoms 100 
specifically for young women using standardised terminology and validated questionnaires. 101 
The second aim was to explore associations between urogenital symptoms and LBP, 102 
obesity, parity, MH and QOL in these women. 103 
Materials and method 104 
Cross-sectional evaluation was conducted using data from participants in the Western 105 
Australian Pregnancy Cohort (Raine) Study at the 22 year-old follow-up [17]. The Raine 106 
Study started as a pregnancy cohort, and included 2868 babies at birth. Participants have 107 
been followed up at regular intervals, with each follow-up including many measures of 108 
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health, disease and demographics. The cohort has retained good representativeness to the 109 
general population [17].  110 
At the 22 year-old follow-up, 1414 participants completed questionnaires investigating a 111 
number of health elements including: urogenital symptoms; current and past history of LBP; 112 
parity; MH and QOL; and a physical examination where height and weight were measured. 113 
Of the 1414 participants, 607 were women and were therefore included in this study.  114 
This project was approved by the Raine Study Executive Committee. Ethical approval was 115 
obtained through Curtin University (RDHS-122-15).   116 
Measures 117 
The seven urogenital symptoms assessed were: UI; SUI; UUI; MUI; bothersome urinary 118 
frequency; difficulty emptying the bladder and urogenital pain. A combined estimate of 119 
prevalence and bother were measured using the Urogenital Distress Inventory-Short Form 120 
(UDI-6) which has established reliability and validity [18]. The participants were asked the 121 
following questions: ‘Do you experience, and, if so, how much are you bothered by: 1. 122 
Frequent urination? (bothersome urinary frequency) 2. Urine leakage related to feeling of 123 
urgency? (Urinary urge incontinence) 3. Urine leakage related to physical activity, coughing 124 
or sneezing? 4. Small amounts of urine leakage (drops)?  5. Difficulty emptying your 125 
bladder?  6. Pain or discomfort in the lower abdomen/genital area?’ (urogenital pain). A 126 
urogenital symptom was considered to be present and bothersome when a response of 127 
slightly, moderately or greatly was given to any one of the questions. 128 
SUI was defined when a response of either slightly, moderately or greatly was given to 129 
leaking urine related to physical activity, coughing or sneezing.  Although small amounts of 130 
urine leakage (drops) is considered as a stress symptom in terms of the UDI-6, potentially it 131 
could be any form of UI and therefore in this study it was analyzed separately. MUI was 132 
considered when a response of either slightly, moderately or greatly was given to question 2 133 
(UUI) and question 3 (SUI) or question 4 (leakage of drops).   134 
The pelvic floor impact questionnaire- short-form 7 (PFIQ-7) has established validity and 135 
reliability for assessing the impact of urogenital symptoms on QOL in women [19]. Seven 136 
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questions ask if urinary problems/pain or discomfort have affected ability to do household 137 
chores, physical activities, entertainment activities, travel, participate in social activities, 138 
emotional health and frustration [20]. For this study the responses were scored as follows: 139 
not at all=0; slightly=1; greatly and moderately were scored together due to low numbers=2. 140 
Scores were added, with a minimum score of 0 indicating no impact and 14 indicating 141 
maximal impact.  142 
LBP prevalence was measured using questions from the modified Nordic Questionnaire 143 
which is both valid and reliable [21].  LBP was classified as: chronic (positive response to 144 
‘Has your low back pain ever lasted for more than three months continuously?’ and/or 145 
positive response to ‘Has your low back pain ever lasted for more than three months off and 146 
on?’); current (positive response to ‘Has your low back been painful at any time in the last 147 
month?’) and ever (positive response to ‘Have you ever had low back pain?’). BMI, was 148 
calculated as weight (kilograms) divided by height (meters) squared, both being reliable and 149 
valid [22 ]. Women were classified as underweight (BMI < 18.5); normal weight (BMI 18.5-150 
<25), overweight  (BMI ≥25-<30) or obese (BMI ≥30) [23]. Parity was ascertained by ‘Do you 151 
have any biological children?’ (no=nulliparous, yes=parous). MH was assessed using the 152 
short-form Depression Anxiety Stress Scale (DASS-21), a valid and reliable measure of 153 
depression, anxiety and stress [24]. QOL was measured using the Short Form 12 Health 154 
Survey (SF-12), which consists of twelve questions assessing physical and mental 155 
wellbeing. It is valid and reliable for assessing QOL in women [25]. Separate physical and 156 
mental component scores were calculated, standardised to a mean of 50 (SD = 10), with 157 
higher scores indicating better QOL [25].  158 
Statistical analysis 159 
Aim 1:  For each urogenital symptom, prevalence for the presence of a bothersome 160 
symptom was estimated. Proportions of women with slight and moderate/great bother, and 161 
with slight (PFIQ-7=1-7) or moderate/great impact (PFIQ-7 >7-14), were calculated.  In 162 
addition, a binary variable was derived denoting the prevalence of having at least one or 163 
more symptoms assessed.  164 
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Aim 2: To examine the associations between each urogenital symptom and LBP, obesity, 165 
parity, mental health and QOL, a series of logistic regressions were estimated. Each 166 
urogenital symptom was considered as the dependent variable, with the reference group 167 
being those without any urogenital symptoms.  168 
Mental health measures (DASS depression, anxiety and stress subscales) displayed skewed 169 
distributions and were parametrised in logistic regression models as ordinal (categories none 170 
(z score >0.5), mild (z-score 0.5-1.0), moderate (z score 1.0 -2.0) severe (z score 2.0-3.0), 171 
extremely severe (z score >3.0) [26] where numbers permitted, or as a binary variable 172 
categories (none or mild versus, moderate or more) to avoid empty or sparse cells for 173 
urogenital symptoms with low prevalence. Estimates for mental health (DASS-21) and QOL 174 
(SF12) were adjusted for the presence of current LBP in instances where the urogenital 175 
symptom was associated with this potential confounder. Odds ratios with associated 95% 176 
confidence intervals and p-values are presented. 177 
Data were analysed using IBM SPSS version 24.0 (Armonk, NY).  P-values <0.05 were 178 
considered statistically significant. 179 
Results 180 
Of the 607 women completing the 22 year follow-up questionnaire, 581/607 (95.6%) 181 
provided valid responses for all six questions assessing the presence of the seven urogenital 182 
symptoms, whilst 588 (96.7%) provided a valid response to one or more of the six questions. 183 
Sample characteristics are shown in Table 1. 184 
Participants reporting at least one current bothersome urogenital symptom were 334/581 185 
(57.5%). The most prevalent type of UI was MUI (11.5%), followed by SUI (6.3%), small 186 
drops of leakage (5.8%), and UUI (5.3%). Prevalence of bothersome urinary frequency was 187 
41.5%, however the majority of these women (62.7%) reported only slight bother (Table 2). 188 
Prevalence of bothersome urinary frequency at moderate/great levels was 15.5%. The 189 
urogenital symptoms that were most bothersome (moderate to great bother) were urogenital 190 
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pain 47/134 (64.9%), frequency 91/244 (37.3%), MUI  22/67 (32.8%), and difficulty emptying 191 
the bladder with 17/69 (24.6%).  In terms of UI, MUI was more bothersome than SUI or UUI 192 
(Table2).  193 
Urogenital symptoms associated with the greatest impact on QOL of young women were 194 
difficulty emptying the bladder 7/67 (10.4%) and urogenital pain 10/131 (7.6%) (Table 2). 195 
Although the majority of women with each symptom did not report any level of impact (i.e. 196 
PRIQ-7=0), slight impact was reported by at least a third of all the young women 197 
experiencing each symptom (Table 2).   198 
Table 3 presents odds ratios for the presence of urogenital symptoms according to LBP, 199 
obesity, parity, and mental/physical health status. The presence of at least one urogenital 200 
symptom was strongly associated with LBP ever (Table 3).  LBP ever and current LBP were 201 
also significantly associated with urinary frequency, SUI, leakage of drops, difficulty 202 
emptying and urogenital pain. Chronic LBP was associated with difficulty emptying the 203 
bladder and urogenital pain (Table 3).  204 
There were no associations between obesity or parity and any urogenital symptoms (Table 205 
3).  206 
Higher levels of depression, anxiety and stress were significantly associated with the 207 
presence of at least one urogenital symptom and also with frequency, MUI, difficulty 208 
emptying and pain (Table 3).  209 
Lower levels of mental component score were associated with the presence of at least one 210 
urogenital symptom and with frequency, MUI, difficulty emptying and pain. Lower levels of 211 
physical component score were not significantly associated with urogenital symptoms (Table 212 
3).   213 
Discussion 214 
Prevalence 215 
This study found that the prevalence of any UI in young, predominantly nulliparous women to 216 
be between 5.3% and 11.5%.  This is higher than the reported prevalence of 0.3% for UI in 217 
15-17 year olds [4], but is lower than the prevalence range of 9.3%-20.4% currently reported 218 
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for women aged younger than 30 [3, 8, 9]. Prevalence data has previously been reported for 219 
mixed aged groups of women: 15-25 years [8], 16-30 [3] and 18-29 [9], whilst the women in 220 
this study were all aged 22 years. This may account for the lower prevalence. It is possible 221 
that at age 22, the downward trend of UI seen in children and adolescents has begun to turn 222 
upwards.  The prevalence of the main subtypes of UI in this study were SUI 6.3%, UUI 5.3% 223 
and MUI 11.5%. The prevalence of SUI and UUI are consistent with the prevalence ranges 224 
currently reported in the literature for women aged younger than 30, SUI 5.9%-7.7% and UUI 225 
3.4%-9% [3, 8, 9].  226 
However, the prevalence of MUI is much higher in this study than the current prevalence 227 
range of MUI 1.9%-5.4% in women aged younger than 30 [3, 8, 9]. This may be due to the 228 
way MUI was defined in the questionnaires used in each of the studies. In the present study, 229 
the UDI-6 was used to measure prevalence of UI subtypes, and leakage of drops of urine 230 
was included in MUI which may have contributed to the higher prevalence. ‘Leakage of 231 
drops’ was analysed separately to SUI as the researchers were not sure that all women 232 
reporting leakage of small drops of urine had SUI. However, the results show that leakage of 233 
drops and SUI behave in a similar way and therefore it is likely that young women are 234 
reporting SUI as leakage of drops. Current literature suggests that the severity of UI 235 
increases with increasing age [4] and given that between 5.3% and 11.5% of the young adult 236 
women in our study are already experiencing a form of UI, screening younger women for UI 237 
would give an opportunity for early intervention.   238 
LUTS such as bothersome urinary frequency, difficulty emptying the bladder and urogenital 239 
pain were prevalent in young women, with 41.5% reporting urinary frequency, 11.8% 240 
reporting difficulty emptying the bladder and 22.9% reporting urogenital pain. These 241 
prevalence ranges are higher than those reported in literature for women aged younger than 242 
39, frequency 7.9% - 9.5%, difficulty emptying the bladder 0.6%-6.0% and bladder pain 3.9% 243 
[11, 12]. However, comparing these results is difficult as different questionnaires and 244 
definitions were used. Definitions used for daytime urinary frequency may be based on the 245 
responder’s perception of whether they void too often per day (as recommended by the 246 
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International Continence Society) or alternatively on a threshold number of voids per day 247 
(Irwin et al 2008).  One study [11] used a responder’s perception based definition  “the 248 
complaint that micturition occurs more frequently than previously deemed normal by the 249 
woman” [10], whilst the other defined urinary frequency as more than 8 voids per day [12]. 250 
The UDI-6 used for the present study includes a responder’s perception type question where 251 
the young women were asked if they experienced urinary frequency and if so, how much 252 
were they bothered by it.  No data were collected on the number of voids per day or fluid 253 
intake. Irwin et al (2008) compared prevalence of ICS defined frequency (responder 254 
perception) with a numerical threshold of more than 8 voids per day in a population-based 255 
sample. They found the prevalence of urinary frequency was higher using the perception 256 
definition than using the numerical threshold definition (25% versus 19% of women with 257 
overactive bladder) [28] . This may, in part, explain the higher prevalence of frequency in our 258 
sample.  Nonetheless, further research into the number of day voids and fluid intake in 259 
young Australian women is recommended to obtain a better understanding of urinary 260 
frequency in this group and whether it is related to higher fluid intake or other lifestyle 261 
factors.  262 
For difficulty emptying the bladder, the young women in the present study were asked 263 
whether they experienced and if so were they bothered by difficulty emptying the bladder. In 264 
other studies the International Continence Foundation definitions are used, in which difficulty 265 
emptying the bladder is described more specifically such as straining, hesitancy, 266 
intermittency or slow stream, which may explain the higher numbers in this study [10-12].  267 
The pain definition used in the present study was quite broad, ‘pain or discomfort in the 268 
lower abdomen/genital area’, whereas in other studies women were asked about bladder 269 
pain, hence the likely reason for the higher prevalence in this study. In addition, a recent 270 
study reported the prevalence of severe menstrual pain in this same cohort of young women 271 
aged at 20 and 22 years to be 17%  [27]. Further investigation of urogenital pain and 272 
menstrual pain in the cohort may be useful, given there could be potential shared underlying 273 
pain mechanisms.  274 
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Bother and Impact  275 
Urogenital pain, urinary frequency and difficulty emptying the bladder were found to be most 276 
bothersome by the young women in this study, and MUI was found to be more bothersome 277 
than SUI and UUI.  Urogenital symptoms associated with the greatest impact on the QOL of 278 
young women were difficulty emptying the bladder and urogenital pain, which is similar to 279 
current literature including older women [1, 5, 6]. In terms of impact, at least a third of all the 280 
young women who reported having each urogenital symptom reported slight impact on their 281 
ability to perform simple daily activities. Whilst this proportion is fairly small, it is important to 282 
remember the young age of these women, and that the tasks being affected are normal 283 
activities of daily living such as shopping, entertaining and household chores.  Previous 284 
studies have found that UI in young women is also associated with adverse impact on daily 285 
life such as limiting fluid intake, wearing pads due to fear of odour,  as well as poorer overall 286 
well-being [3, 8]. 287 
Correlates of urogenital symptoms 288 
Lower back pain 289 
Strong associations were identified between the presence of at least one urogenital 290 
symptom and both LBP ever and current LBP, with SUI and leakage of drops being 291 
associated with current LBP and a history of LBP ever. This appears consistent with the 292 
finding that pre-existing and/or new onset UI or LBP can be associated with a higher risk of 293 
developing LBP or UI respectively. [13]. The associations between LBP and UI are likely to 294 
be complex and are not yet fully understood. It has been suggested that sensorimotor 295 
changes linked to altered motor control of muscles including the abdominal, back and PFM, 296 
known to be associated with a history of LBP and UI, may underpin this relationship [13].  297 
In addition, there were strong associations between difficulty emptying the bladder and 298 
urogenital pain with current, chronic and LBP ever. This comorbidity of urogenital pain and 299 
musculoskeletal LBP may relate to shared musculature, or shared underlying pain 300 
mechanisms [14]. In this study, urogenital pain was considered as any pain in the lower 301 
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abdominal or genital area, and as such it is possible that this included some LBP, thus 302 
confounding the data. 303 
Obesity 304 
Obesity was more strongly associated with SUI and leakage of small drops of urine 305 
(although not significant) than with any of the other urogenital symptoms. This may be due to 306 
a lack of power as only 17% of the sample were classified as obese. A sensitivity analysis 307 
did not identify significant associations either. These results are consistent with another 308 
study which reported no association between UI and BMI in young nulligravid women [3]. 309 
However, there is existing strong evidence to suggest that obesity increases intra-abdominal 310 
pressure which then predisposes SUI [4], and that women who become obese at a younger 311 
age are at a higher risk of developing UI in middle age [4, 29]. In light of this, it is 312 
recommended that young women are given advice and education on the risks associated 313 
with being obese, strategies to help reduce their BMI and referred on for early diagnosis and 314 
treatment of SUI. There is good evidence that both reducing BMI and simple, safe 315 
treatments like pelvic floor muscle training can effectively treat and reduce the symptoms of 316 
SUI [4]. The prospective nature of the Raine study means that additional data on the 317 
association between obesity and urogenital symptoms can be gathered as these women 318 
age. 319 
Parity 320 
There was no association between parity and UI, which may be due to the very low number 321 
of parous women in our study (6.1%) thereby reducing the power, or because most of the 322 
parous women had only one baby. However, parity is an established risk factor for UI, with 323 
increasing parity being associated with increased risk of UI, and this association is strongest 324 
for women aged in their thirties and forties [4]. The underlying mechanisms of exactly how 325 
pregnancy and childbirth predispose UI are still not fully understood [4]. Current research 326 
suggests pelvic floor dysfunction may occur as a result of trauma to the muscles, connective 327 
tissue, nerves or blood supply during vaginal birth, which can then predispose women to UI 328 
[4]. It is possible that parity and obesity were not found to be associated with urogenital 329 
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symptoms in this study due to the relatively young, same aged (all 22 years old) mostly 330 
nulliparous sample. Previous studies finding associations have been in older or mixed age 331 
samples, and it may be that the influence of BMI becomes greater with age and parity. 332 
Mental health and quality of life 333 
The results suggest significantly poorer DASS and SF-12 scores in young women with 334 
urogenital symptoms as opposed to those without urogenital symptoms, even after 335 
adjustment for comorbid LBP. However, the mean SF-12 scores for the young women with 336 
urogenital symptoms were within one standard deviation of the population mean (PCS=52.6; 337 
MCS=43.7), and the difference in these scores between those with and without urogenital 338 
symptoms was, although statistically significant, only 1.6 and 2.7 points respectively. 339 
Therefore, the clinical relevance of the association between urogenital symptoms, 340 
particularly urogenital pain, and poorer MH in young women, is difficult to ascertain. Previous 341 
studies that have reported an association between urogenital symptoms and poorer MH and 342 
QOL in middle aged and older women [4-6], and therefore it would be recommended that 343 
any young women presenting with urogenital symptoms are screened for MH and QOL.  The 344 
prospective nature of the Raine study may provide insight into these associations in future 345 
follow-up studies.  346 
Our results also showed an association between MUI and higher depression, anxiety and 347 
stress scores, which is in accordance with previous studies which included middle and older 348 
ages women [5, 30]. An association between UI and depression, and MUI and anxiety have 349 
been reported in the literature, however the underlying mechanisms for the observed 350 
associations are complex and not yet fully understood [4, 5].  351 
Significance and implications  352 
The results indicate that urogenital symptoms are prevalent and bothersome in young 353 
women, and are associated with significant impact including poorer MH and QOL. Research 354 
has shown that many women who experience  urogenital symptoms do not seek help [7], 355 
and that younger women have little insight into their urogenital health [8]. It is therefore 356 
recommended that primary prevention programs are developed such as community-based 357 
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education sessions, and that health professionals screen young women for urogenital 358 
symptoms and impact during routine episodes of care.  Whilst there is Level 1 evidence that 359 
simple, safe, cost-effective treatments such as pelvic floor muscle training are effective for 360 
treating and reducing urogenital symptoms [31], optimal management of urogenital 361 
symptoms requires a multidimensional view which considers physical health, LBP history, 362 
MH and QOL to minimise impact on young women. The Raine Study is a prospective study 363 
and as such there is great potential for further follow up of these women to obtain more 364 
detailed information and data on trajectories of urogenital symptoms and associated factors. 365 
This study  involved a community sample of women of the same age, thus minimising 366 
selection bias. 367 
Limitations of study and Recommendations  368 
The urogenital symptoms were based on self-report by the participants, and therefore there 369 
is potential for misclassification, especially for those who reported leakage of small drops of 370 
urine. Not all young women were able to attend the physical examination, and therefore 371 
numbers available for estimation of the association BMI with urogenital symptoms were 372 
smaller.  373 
As this is a cross-sectional evaluation, the findings are associations and no causality can be 374 
drawn. Further research is recommended to establish: the prevalence of other types of UI in 375 
young women, (such as post micturition dribble and passive incontinence which are not 376 
included in the UDI-6); to study specific pain syndromes such as bladder pain syndrome, 377 
chronic pelvic pain and urethral pain syndrome; and to determine the direction and 378 
underlying mechanisms of the associations between urogenital symptoms and QOL and MH 379 
in young women. A limitation of the study is that the association of sexual activity with 380 
urogenital symptoms was not assessed, as sexually active women may be at a higher risk of 381 
having lower urinary tract symptoms. 382 
Conclusion 383 
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Urogenital symptoms are both prevalent and bothersome in some young women. They are 384 
associated with LBP, poorer MH and QOL, and functional impacts. 385 
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 483 
Table 1:  Response rates and sample characteristics 484 
 485 
Correlates Number 
providing data   
N (%) 
Number affected 
N (%) 
Low back pain   
     LBP ever  585 (99.5) 406 (69.4) 
     LBP current  583 (99.1) 308 (52.8) 
     LBP chronic 583 (99.1) 225 (38.6) 
BMI a 478 (81.3)  
     Underweight   22 (4.6) 
     Normal   284 (59.4) 
     Overweight  89 (18.6) 
     Obese   83 (17.4) 
Parity 588 (100)  
     Nulliparous  230 (93.1) 
DASS-21   
     Depression 583 (99.1)  
           None  380 (65.2) 
           Mild  73(12.5) 
           Moderate  65 (11.2) 
           Severe  32 (5.5) 
           Extremely severe  33 (5.7) 
     Anxiety 582 (98.9)  
           None  412 (70.8) 
           Mild  41(7.0) 
           Moderate  75 (12.9) 
           Severe  27 (4.6) 
           Extremely severe  27 (4.6) 
     Stress 581 (98.8)  
           None  432 (74.4) 
           Mild  45 (7.8) 
           Moderate  53 (9.1) 
           Severe  37 (6.4) 
           Extremely severe  14 (2.4) 
SF-12 b  573 (97.4)  
       Physical component score  53.3 (7.2) 
       Mental component score  44.8 (10.7) 
 486 
a BMI was not measured for 110 women (18.7%) as they did not attend the physical examination.   487 
Women were classified as either obese (BMI ≥30) or non-obese (BMI<30) in regression models. 488 
b The physical and mental component scores are reported as mean (SD)  489 
 490 
 491 
 492 
 493 
 494 
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 495 
Table 2: Prevalence, bother and level of impact associated with urogenital symptoms. 496 
Urogenital 
symptom 
Presence of 
symptom  
N (% of total  
sample) 
 Severity of Bother a 
N (% of those with the symptom) 
 Level of impact b 
N (% of those with the 
symptom) 
 
Yes 
 
 
Slight Moderate/ 
Great 
 
Slight 
(1-7) 
Moderate 
(>7) 
 
n  
(%) 
 
n  
(%) 
n 
(%) 
 
N 
% 
N 
% 
Frequency 244 of 588 
(41.5)  
153 of 244 
(62.7) 
91 of 244  
(37.3)  
86 of 237 
(36.3) 
8 of 237 
(3.4) 
 
UUI 31 of 583 
 (5.3)  
26 of 31 
 (83.9) 
5 of 31 
 (16.1)  
11 of 30 
(36.7) 
0 of 30  
(0.0) 
 
SUI 37 of 583 
 (6.3)  
34 of 37 
 (91.9) 
3 of 37 
 (8.1)  
14 of 37 
(37.8) 
1 of 37 
 (2.7) 
 
MUI 67 of 583 
(11.5)  
45 of 67 
 (67.2) 
22 of 67 
 (32.8)  
26 of 66 
(39.4) 
5 of 66 
 (7.6) 
 
Leakage of 
small drops 
 
34 of 583 
 (5.8)  
30 of 34 
 (88.2) 
4 of 34 
 (11.8)  
13 of 33 
(39.4) 
0 of 33 
 (0.0) 
Difficulty 
emptying 
bladder 
 
69 of 584 
(11.8) 
 
52 of 69 
 (75.4) 
17 of 69 
 (24.6) 
 
31 of 67 
(46.3) 
7 of 67  
(10.4) 
Pain 134 of 584 
(22.9) 
 
87 of 134 
 (64.9) 
47 of 134  
(35.1) 
 
62 of 131 
(47.3) 
10 of 131 
(7.6) 
UUI  urinary urge incontinence, SUI  stress urinary incontinence, MUI mixed urinary incontinence, leakage of small drops  497 
small drops of urinary leakage 498 
Of the 607 women who completed the 22 year follow-up questionnaire, 581/607 (95.6%) provided valid responses for all 6 499 
questions of the UDI-6), whilst 588 (96.7%) provided a valid response to one or more of the 6 questions. 500 
a The level of bother was calculated from responses to the UDI-6 and is therefore only given for women who had the particular 501 
urogenital symptom. Percentage of subjects with presence of stated urogenital symptom 502 
b The level of impact was calculated from responses to the PFIQ-7and therefore is only given for the women who had the 503 
particular urogenital symptom. Percentage of subjects with presence of stated urogenital symptom. 504 
 505 
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Table 3: Comparisons of LBP, obesity, parity, mental and physical health in those 588 participants who provided a valid response to the UDI-6 506 
. 507 
  No 
Symptoms 
At least one UG 
symptom 
Frequency UUI SUI 
  n= 247a n=334a OR 
95% CI 
p-value 
n=244a OR 
95% CI 
p-value 
n=31a OR 
95% CI 
p-value 
n=37a OR 
95% CI 
p-value 
LBP ever  
 
 151  
(61.6%) 
248  
(74.5%) 
1.82* 
1.27-
2.59* 
.001* 
181 
(74.5%) 
1.82* 
1.23-
2.68* 
.002* 
18 
(58.1%) 
0.86 
0.40-
1.84 
.701 
31 
(83.8%) 
3.22* 
1.29-
8.00* 
.012* 
LBP current  
 
 108 
(44.3%) 
194  
(58.4%) 
1.77* 
1.27-
2.47* 
.001* 
137 
(56.6%) 
1.64* 
1.15-
2.35* 
.007* 
14 
(45.2%) 
1.04 
0.49-
2.20 
.924 
24 
(64.9%) 
2.32* 
1.13-
4.78* 
.022* 
LBP chronic 
 
 83  
(34.2%) 
136  
(40.8%) 
1.33 
0.94-
1.88 
.103 
104 
(42.8%) 
1.44 
1.00-2.08 
.051 
7 
(22.6%) 
0.56 
0.23-
1.36 
.201 
16 
(43.2%) 
1.47 
0.73-
2.96 
.283 
Obese  
(BMI>30) 
 32 
(16.5%) 
51  
(18.4%) 
1.14 
0.70-
1.86 
.591 
33 
(16.3%) 
0.99 
0.58-1.68 
.966 
4 
(16.7%) 
1.01 
0.32-
3.16 
.983 
9 
(27.3%) 
1.90 
0.81-
4.46 
.142 
Nulliparous  230  
(93.1%) 
315  
(94.3%) 
1.23 
0.63-
2.42 
.556 
230 
(94.3%) 
1.21 
0.58-2.52 
.602 
28 
(90.3%) 
0.69 
0.19-
2.50 
.572 
33 
(89.2%) 
0.61 
0.19-
1.92 
.399 
DASS depression 
(moderate or 
more) 
 46 
(18.8%) 
83 
(25.1%) 
1.19*b,c 
1.03-
1.38* 
.018* 
66 
(27.3%) 
1.21*b,c 
1.03-
1.41* 
.019* 
6 
(20.0%) 
1.08e 
0.42-
2.80 
.872 
12 
(32.4%) 
1.92c,e 
0.89-
4.15 
.099 
DASS anxiety  37 90 1.26*b,c 68 1.28*b,c 6 1.34e 8 1.32c,e 
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(moderate or 
more) 
(15.2%) (27.2%) 1.07-
1.47* 
.004* 
(28.2%) 1.08-
2.13* 
.004* 
(20.0%) 0.52-
3.50 
.546 
(21.6%) 0.55-
3.19 
.531 
DASS stress 
(moderate or 
more) 
 31 
(12.8%) 
71 
(21.5%) 
1.28*b,c 
1.07-
1.52* 
.006* 
54 
(22.3%) 
1.30*b,c 
1.08-
1.56* 
.005* 
6 
(20.0%) 
1.64e 
0.62-
4.32 
.315 
5 
(13.9%) 
1.08c,e 
0.39-
3.03 
.878 
SF12 PCS  
(mean, SD) 
 54.2  
(6.6) 
52.6 
(7.5) 
0.98c,d 
0.95-
1.00 
.069 
52.5 
(7.9) 
0.98c,d 
0.95-1.00 
.067 
53.0 
(6.1) 
0.98d 
0.93-
1.03 
.383 
54.0 
(6.9) 
1.01c,d 
0.96-
1.06 
.796 
SF12 MCS  
(mean, SD) 
 46.5  
(10.7) 
43.6 
(10.6) 
0.98*c,d 
0.96-
0.99* 
.005* 
43.5 
(10.8) 
0.98*c,d 
0.96-
0.99* 
.008* 
43.9 
(10.8) 
0.98d 
0.95-
1.01 
.214 
42.0 
(12.4) 
0.97c,d 
0.94-
1.00 
.066 
  No 
Symptoms 
MUI Small drops Difficulty Emptying Pain 
  n= 247a n=67a OR 
95% CI 
p-value 
n=34a OR 
95% CI 
p-value 
n=69a OR 
95% CI 
p-value 
n=134a OR 
95% CI 
p-value 
LBP ever  151  
(61.6%) 
46 
(68.7%) 
1.36 
0.77-
2.43 
.292 
31 
(91.2%) 
6.43* 
1.91-
21.63* 
.003* 
54 
(78.3%) 
2.24* 
1.20-
4.20* 
.012* 
107 
(79.9%) 
2.47* 
1.50-
4.04* 
<.001* 
LBP current  108 
(44.3%) 
35 
(52.2%) 
1.38 
0.80-
2.37 
.247 
26 
(76.5%) 
1.09* 
1.78-
9.40* 
.001* 
43 
(62.3%) 
2.08* 
1.20-
3.60* 
.009* 
87 
(64.9%) 
2.33* 
1.51-
3.60* 
<.001* 
LBP chronic  83  
(34.2%) 
30 
(44.8) 
1.56 
0.90-
2.71 
.111 
16 
(47.1%) 
1.71 
0.83-3.53 
.145 
34 
(49.3%) 
1.87* 
1.08-
3.22* 
.023* 
67 
(50.0%) 
1.93* 
1.25-
2.96* 
.003* 
Obese   32 13 1.50 8 2.13 10 1.05 19 1.01 
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(BMI>30) (16.5%) (22.8%) 0.72-
3.09 
.277 
(29.6%) 0.86-5.29 
.103 
(17.2%) 0.48-
2.30 
.894 
(16.7%) 0.54-
1.89 
.969 
Nulliparous  230  
(93.1%) 
60 
(89.6%) 
0.63 
0.25-
1.60 
.333 
33 
(97.1%) 
2.44 
0.31-
18.94 
.394 
64 
(92.8%) 
0.95 
0.34-
2.66 
.916 
126 
(94.0%) 
1.16 
0.49-
2.77 
.731 
DASS depression   46 
(18.8%) 
21 
(31.8%) 
1.34*b 
1.08-
1.66* 
.007* 
6 
(17.7%) 
0.84c,e 
0.32-2.19 
.720 
24 
(34.8%) 
1.37*b,c 
1.11-
1.69* 
.003* 
44 
(33.1%) 
1.39*b,c 
1.17-
1.66* 
<.001* 
DASS anxiety 
 
 37 
(15.2%) 
23 
(34.9%) 
1.41*b 
1.13-
1.75* 
.002* 
9 
(26.5%) 
1.60c,e 
0.67-3.82 
.284 
29 
(42.0%) 
1.51*b,c 
1.21-
1.86* 
<.001* 
45 
(34.1%) 
1.41*b,c 
1.18-
1.68* 
<.001* 
DASS stress 
 
 31 
(12.8%) 
21 
(31.3%) 
1.47*b 
1.15-
1.88* 
.002* 
8 
(25.5%) 
2.01 
0.81-4.99 
.130 
21 
(30.4%) 
1.52* 
1.21-
1.91* 
<.001* 
45 
(34.1%) 
1.62*b,c 
1.32-
1.98* 
<.001* 
SF12 PCS  
(mean, SD) 
 54.2  
(6.6) 
52.1 
(8.4) 
0.97 
0.93-
1.00 
.063 
52.3 
(7.4) 
0.98 
0.94-1.03 
.467 
51.5 
(9.3) 
0.97 
0.93-
1.00 
.056 
51.7 
(8.7) 
0.97 
0.94-
1.00 
.051 
SF12 MCS  
(mean, SD) 
 46.5  
(10.7) 
42.7 
(11.4) 
0.97* 
0.95-
0.99* 
.013* 
44.0 
(9.9) 
0.99 
0.96-1.02 
.529 
41.5 
(11.5) 
0.97* 
0.94-
0.99* 
.005* 
41.0 
(10.5) 
0.96* 
0.94-
0.98* 
<.001* 
UG urogenital,  UUI  urinary urge incontinence, SUI  stress urinary incontinence, MUI mixed urinary incontinence, leakage of small drops  small drops of urinary leakage ,difficulty emptying difficulty emptying the bladder, pain urogenital pain,  LBP 508 
low back pain, DASS Depression Anxiety Stress Scale short version, SF-12 Short Form 12 Health Survey, PCS physical component score, MCS mental component score  509 
*statistically significant odds ratios 510 
apercentages for independent variables are column percentages with number available for analysis with/without UG symptom as the denominator 511 
bOdds Ratio represents proportional increase in odds for UG symptom for 1 increment of the 5 categories (none, mild, moderate, severe, extremely severe) 512 
of DASS-21 score. (descriptives collapsed by moderate of more  presented for brevity) 513 
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cadjusted for current LBP 514 
dOdds Ratio represents proportional decrease in odds for UG symptom for each increment of 1 in SF score.  515 
eCategories collapsed due to sparse cells. Odds Ratio presents proportional increase in odds for UG symptom for category (moderate, severe, extremely 516 
severe) compared to category (none, mild) of DASS-21 score. 517 
 518 
 519 
 520 
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